본문 바로가기 주메뉴 바로가기

제품소개

제품상세페이지

Proteogenix

[Proteogenix] Theralizumab Biosimilar – Anti-CD28 mAb – Research Grade

Cat-No. PX-TA1927


Proteogenix는 Primary Antibody Biosimilar - Research Grade 

제품을 전문적으로 생산하는 20년의 경험이 있는 High Quality 제조사입니다.




제품 설명 


Theralizumab Biosimilar – Anti-CD28 mAb – Research Grade

  



제품 번호

 

PX-TA1927

 



제품 특징


Product nameTheralizumab Biosimilar - Anti-CD28 mAb - Research Grade
SourceTGN1412, TAB08, CAS: 906068-56-2
SpeciesHumanized
Expression systemXtenCHO
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3 week if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /Synonymsanti-CD28, TP44, T-cell-specific surface glycoprotein CD28,TGN1412, TAB08
ReferencePX-TA1927
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4
ClonalityMonoclonal Antibody




QC & Validation Data


SDS-PAGE for Theralizumab Biosimilar - Anti-CD28 mAb

Theralizumab Biosimilar - Anti-CD28 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.




ProteoGenix의 모든 제품들을 만나보세요!

 

Proteogenix - Exclusive Distributor in South Korea "Morebio" 한국 독점 대리점 "모아바이오"